P2X7 Receptors in Oligodendrocytes: A Novel Target for Neuroprotection

被引：56
|
作者：
Matute, Carlos [1 ,2 ]
机构：
[1] Univ Basque Country, CIBERNED, Dept Neurociencias, Leioa 48940, Spain
[2] Neurotek UPV EHU, Zamudio 48170, Spain
来源：
MOLECULAR NEUROBIOLOGY | 2008年 / 38卷 / 02期
关键词：
Oligodendroglia; Myelin; ATP; P2X7; Ischemia; Multiple sclerosis;
D O I：
10.1007/s12035-008-8028-x
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Intense ATP signaling through P2X7 purinergic receptors can lead to excitotoxicity, a feature which initiates neuronal demise in experimental paradigms relevant to ischemia and to traumatic injury. In addition, recent data provide evidence that oligodendrocytes also express P2X7 receptors that are activated under experimental pathological conditions involving white matter demise. Thus, this receptor subtype is a promising target for the development of new drugs to prevent white matter damage in acute and chronic diseases.
引用
收藏
页码：123 / 128
页数：6
相关论文
共 50 条
  • [1] P2X7 Receptors in Oligodendrocytes: A Novel Target for Neuroprotection
    Carlos Matute
    Molecular Neurobiology, 2008, 38 : 123 - 128
  • [2] P2X7 receptors mediate ischemic damage to oligodendrocytes
    Domercq, M.
    Aparicio, D.
    Perez-Samartin, A.
    Alberdi, E.
    Matute, C.
    NEURON GLIA BIOLOGY, 2007, 2 : S160 - S160
  • [3] P2X7 Receptors Mediate Ischemic Damage to Oligodendrocytes
    Domercq, Maria
    Perez-Samartin, Alberto
    Aparicio, David
    Alberdi, Elena
    Pampliega, Olatz
    Matute, Carlos
    GLIA, 2010, 58 (06) : 730 - 740
  • [4] P2X7: a target for neuroprotection and neuroinflammation in multiple sclerosis
    Gruber, R.
    Woodworth, L.
    Radzwilli, K.
    LaMorte, M.
    Pevarello, P.
    Ofengeim, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 695 - 695
  • [5] P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases
    Cisneros-Mejorado, Abraham J.
    Perez-Samartin, Alberto
    Domercq, Maria
    Arellano, Rogelio O.
    Gottlieb, Miroslav
    Koch-Nolte, Friedrich
    Matute, Carlos
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [6] P2X7 receptors are a potential novel target for anti-glioma therapies
    Mastura Monif
    Terence J O’Brien
    Kate J Drummond
    Christopher A Reid
    Simon V Liubinas
    David A Williams
    Journal of Inflammation, 11
  • [7] P2X7 receptors are a potential novel target for anti-glioma therapies
    Monif, Mastura
    O'Brien, Terence J.
    Drummond, Kate J.
    Reid, Christopher A.
    Liubinas, Simon V.
    Williams, David A.
    JOURNAL OF INFLAMMATION-LONDON, 2014, 11
  • [8] P2X7 receptors and klotho
    Robert Unwin
    Purinergic Signalling, 2020, 16 : 151 - 152
  • [9] P2X7 receptors: a new target in the treatment of depressive disorders
    Soproni, K.
    Zelena, D.
    Haller, J.
    Nemeth, T.
    Mocsai, A.
    ACTA PHYSIOLOGICA HUNGARICA, 2010, 97 (04) : 473 - 474
  • [10] P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease
    Shokoples, Brandon G.
    Paradis, Pierre
    Schiffrin, Ernesto L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (01) : 186 - 199
12345